Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: The Atherosclerosis Risk in Communities (ARIC) carotid MRI study

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 596-602

  Virani, Salim S ^a,b,c   Catellier, Diane J ^d   Pompeii, Lisa A ^e   Nambi, Vijay ^b,c   Hoogeveen, Ron C ^b,c   Wasserman, Bruce A ^f   Coresh, Josef ^g   Mosley, Thomas H ^h   Otvos, James D ⁱ   Sharrett, A Richey ^g   Boerwinkle, Eric ^e   Ballantyne, Christie M ^b,c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f DEPARTMENT OF PATHOLOGY   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

ⁱ LIPOSCIENCE INC   (United States)

Author keywords

Anti atherogenic lipoproteins; Atherogenic lipoproteins; Lipid rich necrotic core; Plaque burden

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANTIHYPERTENSIVE THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE BURDEN; BLOOD VESSEL PARAMETERS; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DRUG USE; FEMALE; HUMAN; HYPERTENSION; LIPID RICH CORE PRESENCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL HISTORY; PARTICLE SIZE; PLAQUE ECCENTRICITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING;

AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONTRAST MEDIA; CROSS-SECTIONAL STUDIES; FEMALE; GADOLINIUM DTPA; HUMANS; LINEAR MODELS; LIPOPROTEINS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84860400571     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.001     Document Type: Article

References (24)

1. Cromwell W.C., Otvos J.D. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100mg/dl. Am J Cardiol 2006, 98:1599-1602.
2. Sniderman A., Williams K., Cobbaert C. ApoB versus non-HDL-C: what to do when they disagree. Curr Atheroscler Rep 2009, 11:358-363.
3. Davies M.J., Richardson P.D., Woolf N., Katz D.R., Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993, 69:377-381.
4. Anitschkow N., Chalatow S. Classics in arteriosclerosis research: On experimental cholesterin steatosis and its significance in the origin of some pathological processes [translated by Mary Z. Pelias, 1913]. Arteriosclerosis 1983, 3:178-182.
5. Carew T.E., Koschinsky T., Hayes S.B., Steinberg D. A mechanism by which high-density lipoproteins may slow the atherogenic process. Lancet 1976, 1:1315-1317.
6. Nambi V., Chambless L., Folsom A.R., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010, 55:1600-1607.
7. Hatsukami T.S., Ross R., Polissar N.L., Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000, 102:959-964.
8. Trivedi R.A., U-King-Im J.M., Graves M.J., et al. MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 2004, 46:738-743.
9. Yuan C., Mitsumori L.M., Ferguson M.S., et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001, 104:2051-2056.
10. Wagenknecht L., Wasserman B., Chambless L., et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging 2009, 2:314-322.
11. Mani V., Muntner P., Gidding S.S., et al. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events. J Cardiovasc Magn Reson 2009, 11:10.
12. Kerwin W., Xu D., Liu F., et al. Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging 2007, 18:371-378.
13. Gaubatz J.W., Ballantyne C.M., Wasserman B.A., et al. Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study. Arterioscler Thromb Vasc Biol 2010, 30:1034-1042.
14. Wasserman B.A., Astor B.C., Sharrett A.R., Swingen C., Catellier D. MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging 2010, 31:406-415.
15. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989, 129:687-702.
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
17. Jeyarajah E.J., Cromwell W.C., Otvos J.D. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006, 26:847-870.
18. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
19. Mora S., Szklo M., Otvos J.D., et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 192:211-217.
20. Crouse J.R., Goldbourt U., Evans G., et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1996, 27:69-75.
21. Paramsothy P., Knopp R.H., Bertoni A.G., et al. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010, 56:1034-1041.
22. Blaha M., Blumenthal R., Brinton E., Jacobson T. The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol 2008, 2:267-273.
23. Brunzell J.D., Davidson M., Furberg C.D., et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008, 51:1512-1524.
24. Robinson J.G. Are you targeting non-high-density lipoprotein cholesterol?. J Am Coll Cardiol 2009, 55:42-44.